ALLO vs ELV · rev $22.0K vs P/E 18, rev $199.13B
Allogene Therapeutics Inc (ALLO) versus Elevance Health Inc (ELV) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
ALLO currently screens at market cap $258.1M. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Not investment advice. Open the ALLO and ELV stock pages for the full models.
Not investment advice.